2022 International Headache Academy

*The Application Period for the 2022 Program is Now Closed*

PROGRAM GOALS
The International Headache Academy is designed to inspire a long-term commitment to headache medicine in young neurologists and research scientists via an educational program focused on clinical and research aspects of the field.

The American Headache Society is dedicated to mentoring future leaders in headache medicine through both outreach and continued education.

The Eighth IHA will be held March 24-26, 2022 at the UCLA Meyer and Renee Luskin Conference Center in Los Angeles, CA.

HEALTH AND SAFETY
The AHS is committed to ensuring your health and safety during IHA. All attendees and faculty are required to be vaccinated against the COVID-19 virus (at least 14 days after receiving the second Pfizer or Moderna dose or the Johnson and Johnson dose) prior to arriving to the meeting. Participants will need to provide proof of vaccination (a vaccine card or picture) during badge pickup.

Masks are required for all participants while inside the meeting space, except during eating or drinking. Masks are encouraged during outdoor events as well.

Social Distancing will be encouraged and seating during sessions will allow for more personal space.

IHA Planning and Research Committee Co-Chairs

Elizabeth Leroux, MD Clinique de la Migraine Montreal, Quebec

William Renthal, MD, PhD, FAHS Brigham and Women’s Hospital/Harvard Medical School Boston, Massachusetts

PURPOSE/OBJECTIVE

At the conclusion of the program, participants will be able to:

• Identify and describe the role of physiologic structures and systems involved in migraine, cluster headache, and related primary headache conditions
• Diagnose patients presenting with primary and secondary head pain based on data from history-taking, knowledge of diagnostic criteria, and findings from epidemiologic studies
• Develop evidence-based treatment plans involving medications/devices, complementary and alternative medicine, and/or behavioral techniques
• Effectively communicate with headache patients and caregivers, both in eliciting information for history taking and providing information for education
• Remember the steps involved in conducting a clinical trial and preparing the findings for publication
• Explain how Headache Medicine can be a rewarding career choice and a viable practice model and evaluate opportunities to enter or advance in the field

ACCREDITATION STATEMENT

The American Headache Society^® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society^® designates this other activity (live and recorded sessions) for a maximum of 10 AMA PRA Category 1 Credits^™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS FOR CLAIMING CME

• Attend the sessions in full for which credit is sought
• Complete the post-activity evaluation
• A certificate of completion will be available once the evaluation is submitted

DISCLOSURE STATEMENT AND DISCLOSURES

The planners and faculty for this activity have no relevant relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERCIAL SUPPORT

The American Headache Society gratefully acknowledges the educational grants received for the International Headache Academy from our Industry Supporters:

AbbVie Inc.
Amgen Inc.
Lilly USA, LLC
Lundbeck LLC

*The Application Period for the 2022 Program is Now Closed*

Candidate Criteria
Interested applicants must be a PGY 3-4 Resident, headache medicine fellow, or MD and/or PhD clinician/researcher currently enrolled or within 5 years of having completed their training in the US, Canada, or Latin America. Previous participants of IHA are encouraged to apply should you meet eligibility requirements as outlined.

Application and Supporting Materials
Applicants must complete an online application form and provide the following supporting materials:

• CV
• Brief academic update (presentations delivered, abstracts published, manuscripts published or in press, book chapters published or in press, academic promotion, academic appointments, projects funded, or any other update)
• Letter of support from Department Chair, Program Director, or AHS member
• A demonstrated interest in headache medicine
• Completion of statement of interest and financial disclosure form

Applications will be reviewed and rated according to the following:

• Academic history and productivity
• Field of study
• Place of study
• Quality of research to date (if any)
• Potential for the applicant to provide leadership in headache medicine and make meaningful contributions to headache research and/or clinical care for many years

Through submission of an optional research proposal, selected applicants may be eligible to receive a $10,000 grant to fund their research project, and those selected will be invited to present at the 65th Annual Scientific Meeting in 2023.

Accepted applicants will also receive a one-year AHS Trainee membership if not already a member of AHS, or a one-year extension of their existing AHS Trainee membership.

AHS gratefully acknowledges the educational grant support of the 2022 International Headache Academy from our industry supporters:

AbbVie Inc.
Amgen Inc.
Lilly USA, LLC
Lundbeck LLC